急性髓系白血病患者微小残留病监测中IDH2突变的定量检测及其与NPM1基因突变的比较 - Suppr

Suppr

超能文献

Quantitative detection of IDH2 mutation for minimal residual disease monitoring in patients with acute myeloid leukemia and its comparison with mutations in NPM1 gene.

作者信息

Jeziskova Ivana, Razga Filip, Toskova Martina, Dvorakova Dana, Timilsina Shira, Mayer Jiri, Racil Zdenek

出版信息

Leuk Lymphoma. 2013 Apr;54(4):867-70. doi: 10.3109/10428194.2012.727414. Epub 2012 Sep 28.

DOI:10.3109/10428194.2012.727414

PMID:22950897

Abstract

摘要

相似文献

Quantitative detection of IDH2 mutation for minimal residual disease monitoring in patients with acute myeloid leukemia and its comparison with mutations in NPM1 gene.急性髓系白血病患者微小残留病监测中IDH2突变的定量检测及其与NPM1基因突变的比较

Leuk Lymphoma. 2013 Apr;54(4):867-70. doi: 10.3109/10428194.2012.727414. Epub 2012 Sep 28.

IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication.IDH1 和 IDH2 突变是急性髓系白血病中常见的遗传改变，并且在伴有 NPM1 突变但无 FLT3 内部串联重复的核型正常急性髓系白血病中具有不良预后。

J Clin Oncol. 2010 Aug 1;28(22):3636-43. doi: 10.1200/JCO.2010.28.3762. Epub 2010 Jun 21.

IDH1 and IDH2 mutations in patients with acute myeloid leukemia: Suitable targets for minimal residual disease monitoring?急性髓系白血病患者中的异柠檬酸脱氢酶1和异柠檬酸脱氢酶2突变：微小残留病监测的合适靶点？

Clin Biochem. 2018 Nov;61:34-39. doi: 10.1016/j.clinbiochem.2018.08.012. Epub 2018 Aug 31.

Molecular alterations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients.新诊断的急性髓系白血病患者中异柠檬酸脱氢酶 1 和 2（IDH1 和 IDH2）代谢基因的分子改变和其他基因突变。

J Hematol Oncol. 2012 Mar 7;5:5. doi: 10.1186/1756-8722-5-5.

IDH1 and IDH2 mutations confer an adverse effect in patients with acute myeloid leukemia lacking the NPM1 mutation.异柠檬酸脱氢酶1（IDH1）和异柠檬酸脱氢酶2（IDH2）突变对缺乏核仁磷酸蛋白1（NPM1）突变的急性髓系白血病患者具有不良影响。

Eur J Haematol. 2014 Jun;92(6):471-7. doi: 10.1111/ejh.12271. Epub 2014 Mar 3.

Nucleophosmin1 and isocitrate dehydrogenase 1 and 2 as measurable residual disease markers in acute myeloid leukemia.核仁磷酸蛋白 1 和异柠檬酸脱氢酶 1 和 2 作为急性髓系白血病的可测量残留疾病标志物。

PLoS One. 2021 Jun 21;16(6):e0253386. doi: 10.1371/journal.pone.0253386. eCollection 2021.

Evaluation of a New Closed-System Automated RT-qPCR Assay for the Rapid Detection and Monitoring of Common Nucleophosmin Mutations in Patients with Acute Myeloid Leukemia.评价一种新的封闭系统自动化 RT-qPCR 检测方法，用于快速检测和监测急性髓系白血病患者常见核仁磷酸蛋白突变。

Int J Mol Sci. 2024 Jul 19;25(14):7912. doi: 10.3390/ijms25147912.

Serum 2-hydroxyglutarate production in IDH1- and IDH2-mutated de novo acute myeloid leukemia: a study by the Acute Leukemia French Association group.IDH1 和 IDH2 突变的初发急性髓系白血病中的血清 2-羟戊二酸产生：急性白血病法国协会组的一项研究。

J Clin Oncol. 2014 Feb 1;32(4):297-305. doi: 10.1200/JCO.2013.50.2047. Epub 2013 Dec 16.

NPM1-mutant acute myeloid leukemia relapsing as acute lymphoblastic leukemia with clonal persistence of IDH1 mutation.NPM1 突变型急性髓系白血病复发为急性淋巴细胞白血病，伴有 IDH1 突变的克隆性持续存在。

Leuk Lymphoma. 2021 Jul;62(7):1790-1792. doi: 10.1080/10428194.2021.1881510. Epub 2021 Feb 13.

A novel quantitative assessment of minimal residual disease in patients with acute myeloid leukemia carrying NPM1 (nucleophosmin) exon 12 mutations.对携带核仁磷酸蛋白（NPM1）第12外显子突变的急性髓系白血病患者微小残留病的一种新型定量评估。

Leukemia. 2009 Apr;23(4):793-6. doi: 10.1038/leu.2008.268. Epub 2008 Oct 2.

引用本文的文献

Current and Emerging Techniques for Diagnosis and MRD Detection in AML: A Comprehensive Narrative Review.急性髓系白血病诊断及微小残留病检测的当前及新兴技术：一篇全面的叙述性综述

Cancers (Basel). 2023 Feb 21;15(5):1362. doi: 10.3390/cancers15051362.

Measurable Residual Disease Monitoring by Locked Nucleic Acid Quantitative Real-Time PCR Assay for Mutation in Adult AML.采用锁核酸定量实时PCR检测法监测成人急性髓系白血病突变的可测量残留病

Cancers (Basel). 2022 Dec 15;14(24):6205. doi: 10.3390/cancers14246205.

Strategies for minimal residual disease detection: current perspectives.微小残留病检测策略：当前观点

Blood Lymphat Cancer. 2019 Feb 12;9:1-8. doi: 10.2147/BLCTT.S172693. eCollection 2019.

Digital PCR in Myeloid Malignancies: Ready to Replace Quantitative PCR?数字 PCR 在髓系恶性肿瘤中的应用：是否准备好替代实时定量 PCR？

Int J Mol Sci. 2019 May 7;20(9):2249. doi: 10.3390/ijms20092249.

Minimal/Measurable Residual Disease Monitoring in -Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives.伴有突变的急性髓系白血病中的微小残留病监测：临床观点和展望。

Int J Mol Sci. 2018 Nov 6;19(11):3492. doi: 10.3390/ijms19113492.

Clinical relevance of mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA group.在急性髓系白血病随访期间，突变等位基因负担的临床意义。法国 ALFA 集团的一项研究。

Haematologica. 2018 May;103(5):822-829. doi: 10.3324/haematol.2017.183525. Epub 2018 Feb 22.

Novel multiplex bead-based assay for detection of IDH1 and IDH2 mutations in myeloid malignancies.用于检测髓系恶性肿瘤中 IDH1 和 IDH2 突变的新型多重珠基检测方法。

PLoS One. 2013 Sep 30;8(9):e76944. doi: 10.1371/journal.pone.0076944. eCollection 2013.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验